Tuesday, October 18, 2022 4:56:29 PM
exwannabe,
You guys need to sit down and read up on the exceptions to adequate and well controlled trials a few more times. The exceptions pathway is for when things DON’T go as planned like treatment induced pseudoprogression. You have been aware of this for quite some time as one of my first posts on this board in 2016 was related to this pathway. Those claiming post hoc manipulation can not claim ignorance as I have been responded to by all claiming post hoc data manipulation with new analysis measures. There is a big difference between uninformed ignorance while stating a claim and deliberate avoidance of sharing the whole truth while stating a claim both of which can have the ability to steer conclusions in the wrong direction but avoidance points to this steering in the wrong direction being deliberate. Best wishes.
You guys need to sit down and read up on the exceptions to adequate and well controlled trials a few more times. The exceptions pathway is for when things DON’T go as planned like treatment induced pseudoprogression. You have been aware of this for quite some time as one of my first posts on this board in 2016 was related to this pathway. Those claiming post hoc manipulation can not claim ignorance as I have been responded to by all claiming post hoc data manipulation with new analysis measures. There is a big difference between uninformed ignorance while stating a claim and deliberate avoidance of sharing the whole truth while stating a claim both of which can have the ability to steer conclusions in the wrong direction but avoidance points to this steering in the wrong direction being deliberate. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
